Skip to main content
VCbacked
Log inGet Started

Vernal Biosciences

Burlington, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

$20.0M raised
Jun 2023
Series A
BiotechnologyLife ScienceMedical

Top Investors

Alloy TherapeuticsAmpersand Capital PartnersCharles River Laboratories InternationalDynamk CapitalVermont Center for Emerging Technologies

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vernal Biosciences

How much funding has Vernal Biosciences raised?
Vernal Biosciences has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in June 2023.
Who are Vernal Biosciences's investors?
Vernal Biosciences's investors include Alloy Therapeutics, Ampersand Capital Partners, Charles River Laboratories International, Dynamk Capital, Vermont Center for Emerging Technologies.
Where is Vernal Biosciences headquartered?
Vernal Biosciences is headquartered in Burlington, United States.
What does Vernal Biosciences do?
Vernal Biosciences specializes in high-purity mRNA for research and clinical use.
What stage is Vernal Biosciences at?
Vernal Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vernal Biosciences — Funding & Investors." VCBacked, June 27, 2023, https://www.vcbacked.co/company/vernal-biosciences. Accessed June 17, 2026.
APA
VCBacked. (2023). Vernal Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/vernal-biosciences
Wikipedia (cite web)
{{cite web |title=Vernal Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/vernal-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong